Robredo: Low vaccine efficacy may discourage Pinoys from being inoculated

 By Deighton Acuin

PHOTO: Rappler

If the government will choose coronavirus vaccines with low efficacy rate, it may discourage the public to get vaccinated, Vice President Leni Robredo said on Sunday.

“Kasi, Ka Ely [Saludar], iyong pinakamahirap diyan… ang pinaka-kampanya nga natin iyong confidence, ‘di ba, iyong tiwala sa bakuna. Kapag alam ng tao na ang baba ng efficiency o effectivity ng vaccine na ito, ‘di ba, mababa din iyong tiwala,” Robredo said over her radio program, “BISErbisyong Leni” at RMN-dzXL 558 kHz, when sought for comment about the government’s decision to choose China vaccine Sinovac, which has 50 percent efficacy rate.

“Pero kapag alam niya na itong klaseng vaccine na ito, ganito iyong level ng effectivity, ito iyong mga nakuha noong mga kung sino, saang mga bansa, mas tataas iyong tiwala niya sa bakuna, mas maraming magpapabakuna. Pero kung alam na, Ka Ely, na iyong level of effectivity nito mababa, lalong mahihirapan tayong magkampanya na mas maraming tao iyong magpabakuna,” Robredo added.

Robredo said even Chinese vaccines are still acceptable, the government must still provide an explanation on why it still preferring Chinese drugmaker's vaccine than that of vaccines with higher efficacy rate.

“Lalo na kasi, gaya nga ng sabi ko, Ka Ely, na marahil totoo na iyong 50 [percent] acceptable na iyon, pero mahirap kasing ipaliwanag na mayroong iba in the market na mas mura, mas mataas nang di hamak iyong level of [efficacy] —iyong pipiliin natin na mas mahal, mas mababa. Tingin ko, Ka Ely, kailangan ma-explain iyon. Kailangan ma-explain iyon sa tao, bakit ganoon,” she said.

The Department of Science and Technology (DOST) earlier said the efficacy rate of Sinovac vaccine is still acceptable since it is within the requirements imposed by World Health Organization (WHO).

As per report by Senate Finance Committee Chairperson Senator Sonny Angara, Sinovac ranked 2nd from most expensive COVID-19 drug with P3,629 for two doses per individual.

However, vaccines developed by U.S. companies have higher efficacy rates namely Pfizer at 95 percent and Moderna at 94 percent.


RELATED ARTICLE: Philippine Daily Inquirer 

DISCLAIMER


Previous Post Next Post